Shalini K, F M, M J, T H, U U, N J, et al. To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus. IJRPLS [Internet]. 2024 Aug. 7 [cited 2026 Apr. 18];12(02):31-7. Available from: https://pharmaresearchlibrary.org/journals/index.php/ijrpls/article/view/396